13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-06-26 Event 2026-06-24 SEC 0000908834-26-000323 →

FARALLON CAPITAL MANAGEMENT, L.L.C. Centessa Pharmaceuticals plc

Stake: Shares: 0 CUSIP: 152309100 Class: Ordinary Shares, nominal value GBP 0.002 per share (the "Ordinary Shares")

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
1 transaction
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-05-01 Accardi Mario Alberto director, officer F 604 $39.42 $24K

Other 13D/G Filings on Centessa Pharmaceuticals plc

FiledFormFilerStakeShares
2026-06-24 SCHEDULE 13D FARALLON CAPITAL MANAGEMENT, L.L.C. 6.10% 9,370,093 view →

Other Filings by FARALLON CAPITAL MANAGEMENT, L.L.C.

FiledFormIssuerStakeShares
2026-06-24 SCHEDULE 13D Centessa Pharmaceuticals plc 6.10% 9,370,093 view →
2023-03-15 SC Atento S.A. view →
2021-11-15 SC Playa Hotels & Resorts N.V. view →
2021-05-21 SC Playa Hotels & Resorts N.V. view →
2021-01-15 SC Playa Hotels & Resorts N.V. view →
2020-11-24 SC Playa Hotels & Resorts N.V. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →